Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP vs SP+Artesunate for Malaria Prevention in Pregnancy
NCT00164255Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jan 2003
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of artesunate in malaria (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoints: Placental parasitemia and Reported or noted adverse reactions. Started Jan 2003; status: completed.
02
Drugs
artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00164255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164255.